Digital Mammography Market By Product Type (Full Field Digital Mammography (FFDM), Portable Digital Mammography, Tomosynthesis (3D Mammography)), By End-User (Hospitals, Diagnostic Imaging Centers, Research Centers), By Application (Breast Cancer Screening, Diagnostic Imaging, Post-Treatment Monitoring), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Digital Mammography Market was valued at USD 1.3 billion in 2023 and will surpass USD 2.9 billion by 2030; growing at a CAGR of 11.5% during 2024 - 2030.

The digital mammography market has emerged as a crucial segment within the broader medical imaging industry. It enables early detection of breast cancer through advanced imaging systems, offering high-quality, detailed images that are used for diagnosis and screening purposes. The adoption of digital mammography systems is increasing globally, driven by advancements in technology, rising breast cancer awareness, and the need for improved diagnostic accuracy. With innovations in 3D mammography, portable systems, and improvements in image quality, the market is expected to continue growing rapidly over the coming years. The ability to detect breast cancer at an early stage significantly improves treatment outcomes, making digital mammography an essential tool in healthcare.

Full Field Digital Mammography (FFDM) Segment is Largest Owing to Its Reliability and Precision

Among the various types of digital mammography, Full Field Digital Mammography (FFDM) remains the largest segment. FFDM systems have become the standard of care in many healthcare facilities due to their high-resolution imaging capabilities and the ability to provide clear, detailed images of the breast tissue. Unlike traditional film-based mammography, FFDM systems capture digital images that are immediately available for review, reducing the need for reexamination and speeding up the diagnostic process. FFDM’s widespread use in hospitals and diagnostic imaging centers, alongside its proven efficacy in breast cancer detection, continues to drive demand for this technology.

The FFDM segment is particularly popular in developed regions where healthcare infrastructure is well-established, and the demand for high-quality diagnostic equipment is substantial. The increasing preference for non-invasive procedures and the growing awareness of breast cancer are contributing to the ongoing expansion of this segment. FFDM’s ability to provide reliable images for both routine screening and diagnostic purposes positions it as a dominant player in the digital mammography market.

Diagnostic Imaging Centers are the Fastest Growing End-User Segment

The Diagnostic Imaging Centers segment is the fastest growing end-user segment in the digital mammography market. These centers, which specialize in medical imaging, have seen a surge in demand due to the increasing focus on early breast cancer detection and the rising prevalence of the disease. Diagnostic imaging centers offer specialized services that cater to a wide range of diagnostic needs, including mammograms for breast cancer screening. The growing trend of outpatient services and the preference for specialized healthcare have contributed to the growth of this segment.

Diagnostic imaging centers benefit from the adoption of digital mammography technologies, which enhance diagnostic accuracy and speed up the process of imaging, making them a preferred choice for patients seeking timely results. Furthermore, these centers are well-equipped with the latest imaging technologies, such as 3D mammography, offering a more comprehensive and precise diagnostic approach. As the demand for breast cancer screening continues to rise globally, diagnostic imaging centers are increasingly becoming the focal points for advanced mammography procedures.

Breast Cancer Screening is the Largest Application Segment

In terms of applications, Breast Cancer Screening is the largest segment within the digital mammography market. Breast cancer screening is a critical component of public health initiatives aimed at early detection and prevention of breast cancer. Digital mammography, particularly through 3D tomosynthesis, offers a higher degree of accuracy compared to traditional methods, enabling healthcare professionals to identify abnormalities at early stages. This capability has made breast cancer screening the primary driver of digital mammography adoption, particularly in high-risk populations.

Breast cancer screening programs are increasingly being incorporated into national healthcare strategies, with many countries recommending regular mammography screenings for women over a certain age. Additionally, the emphasis on preventive healthcare and early detection of diseases is driving the demand for mammography systems. The increasing integration of digital mammography in routine healthcare check-ups and preventive health programs is expected to continue driving the growth of this segment.

North America is the Largest Region in the Digital Mammography Market

North America is the largest region in the digital mammography market, accounting for a significant share of the overall market due to the region’s advanced healthcare infrastructure and high adoption rates of modern medical technologies. The presence of leading manufacturers, well-established healthcare systems, and strong government support for breast cancer awareness and screening programs make North America the dominant region. In addition, the United States has a high prevalence of breast cancer, driving the demand for early detection and screening technologies, including digital mammography.

The region also benefits from a well-developed reimbursement system that supports the adoption of advanced diagnostic technologies in healthcare facilities. The increasing focus on preventive healthcare in the U.S. and Canada, coupled with the growing number of breast cancer screening programs, continues to fuel the growth of the digital mammography market in North America. With continuous innovations in imaging technology and a robust healthcare framework, North America is expected to retain its dominance in the global digital mammography market.

Leading Companies and Competitive Landscape

The digital mammography market is highly competitive, with several established players offering advanced imaging solutions. Hologic Inc., GE Healthcare, Philips Healthcare, Siemens Healthineers, and Fujifilm Holdings Corporation are some of the leading companies that dominate the market. These companies are investing heavily in research and development to introduce new technologies such as 3D mammography (tomosynthesis) and portable mammography systems. These innovations are aimed at improving diagnostic accuracy, reducing radiation exposure, and making breast cancer screening more accessible.

The competitive landscape is characterized by strategic mergers and acquisitions, partnerships, and product launches. Companies are focusing on expanding their product portfolios, enhancing customer service, and increasing their geographical reach to capitalize on the growing demand for digital mammography systems. The market is also seeing a trend toward the integration of artificial intelligence (AI) in digital mammography systems to improve diagnostic outcomes and streamline workflows. As healthcare providers continue to prioritize early detection and preventive care, the digital mammography market is expected to remain highly dynamic, with new players and technologies emerging over time.

Recent Developments:

• Philips has introduced a new 3D mammography system designed to improve early breast cancer detection with advanced imaging capabilities. The device aims to reduce screening time while enhancing diagnostic precision.
• Hologic has recently expanded its breast imaging portfolio with new tomosynthesis solutions. These systems offer superior image quality and aim to further reduce false positives, enhancing early detection of breast cancer.
• GE Healthcare received FDA approval for its latest digital mammography system, which offers enhanced resolution and faster processing times, improving workflow in busy healthcare facilities.
• Carestream Health has partnered with several healthcare providers to offer advanced digital mammography services in underserved rural areas, aiming to increase access to early breast cancer detection.
• Fujifilm has acquired the mammography business of Analogic Corporation, strengthening its presence in the digital mammography market. The acquisition allows Fujifilm to expand its product offerings and improve customer service in breast imaging.

List of Leading Companies:

• GE Healthcare
• Philips Healthcare
• Siemens Healthineers
• Hologic Inc.
• Carestream Health
• Fujifilm Holdings Corporation
• Canon Medical Systems
• Konica Minolta, Inc.
• Samsung Medison
• Mammotome (Div. of Devicor Medical Products)
• IMS (Imaging Medical Systems)
• Lodox Systems
• Agfa-Gevaert Group
• Analogic Corporation
• Becton Dickinson and Co.

Report Scope: